Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC
Clinical trial NCT06202014 · UNKNOWN
Trial details
- NCT number
- NCT06202014
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-31
- Primary completion
- 2024-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.